Faculty profile
Armen Aprikian
Back to facultyResearch
Read how they describe their research on their McGill University profile.
Latest papers
Prognostic Significance of the Cytoplasmic Expression of UDP-glucuronosyltransferase 2B17 in Localized Prostate Cancer: Insights from the Canadian Prostate Cancer Biomarker Network and PROCURE Multi-institutional Cohorts.
European urology oncology · 2026
Cohort profile: BioCaPPE (Biomarkers of Prostate Cancer/Prevention and Environment) - a Canadian multicentre prospective study of lifestyle and candidate biomarkers in relation to prostate cancer risk.
BMJ open · 2026
Predicting clinically significant prostate cancer with or without digital rectal exam and MRI data using ClarityDX Prostate models
npj Digital Medicine · 2026
Latest funding
- $638,776
Create timely real-world evidence and economic evaluations to improve decisions for patients with prostate cancer
CIHR · 2024 · Co-investigator
- $499,160
The McGill Task Force on the Impact of COVID-19 on Cancer Control and Care: Generating Evidence and Developing Strategies to Mitigate Future Cancer Risk for Canadians
CIHR · 2021 · Co-investigator
- $60,000
Use of glycogen synthase kinase-3B inhibitors (GSK3Is) and prostate cancer risk and prognosis
CIHR · 2020 · Co-investigator
108 publications.
Prognostic Significance of the Cytoplasmic Expression of UDP-glucuronosyltransferase 2B17 in Localized Prostate Cancer: Insights from the Canadian Prostate Cancer Biomarker Network and PROCURE Multi-institutional Cohorts.
Uchil A, Lacombe L, Hovington H, Brisson H, Simonyan D, Caron P, Ouellet V, Latour M, Aprikian A, Bergeron A, Chevalier S, McKercher G, Brimo F, Fazli L, Fleshner N, Gleave M, Karakiewicz PI, Carmel M, Hamilou Z, Trudel D, van der Kwast T, Mes-Masson AM, Dong X, Saad F, Guillemette C, Lévesque E
Cohort profile: BioCaPPE (Biomarkers of Prostate Cancer/Prevention and Environment) - a Canadian multicentre prospective study of lifestyle and candidate biomarkers in relation to prostate cancer risk.
Moussa H, Tourigny R, Robitaille K, Bussières V, Fadel J, Ben Souilah F, Diabaté L, Hovington H, Bettan L, Lacombe L, Dujardin T, Lodde M, Toren P, Aprikian A, Saad F, Carmel M, Jeldres C, Lamarche B, Bergeron A, Fradet Y, Fradet V, Network BIOCaPPE
Predicting clinically significant prostate cancer with or without digital rectal exam and MRI data using ClarityDX Prostate models
Robert J. Paproski, Adam S. Kinnaird, M. Eric Hyndman, Adrian Fairey, Leonard S. Marks, Christian P. Pavlovich, Sean A. Fletcher, Roman Zachoval, Vanda Adamcová, Jiří Stejskal, Armen Garo Aprikian, Christopher J. D. Wallis, Desmond Pink, Catalina Vásquez, Perrin H. Beatty, John D. Lewis
Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.
Bancroft EK, Page EC, McHugh J, Thomas S, Taylor N, Pope J, Evans DG, Rothwell J, Grindedal EM, Maehle L, James P, McKinley J, Mascarenhas L, Side L, Thomas T, van Leerdam ME, van Asperen CJ, Kiemeney LALM, Ringelberg J, Vlaming M, Rønlund K, Osther PJS, Helfand BT, Hutten CG, Oldenburg RA, Cybulski C, Wokolorczyk D, Ong KR, Huber C, Salinas M, Feliubadaló L, Oosterwijk JC, van Zelst-Stams WAG, Cook J, Rosario DJ, Maxwell K, Powers J, Buys S, Lyman J, Ausems MGEM, Schmutzler RK, Rhiem K, Izatt L, Tripathi V, Teixeira MR, Cardoso M, Foulkes WD, Aprikian A, Davidson R, Longmuir M, Ruijs MWG, Blom EW, van Engelen K, Williams R, Andrews L, Murphy DG, Saya S, Halliday D, Walker L, Liljegren A, Carlsson S, Azzabi A, Jobson I, Snape K, Gowie M, Harris M, Tischkowitz M, Taylor A, Kirk J, Susman R, Chen-Shtoyerman R, Spigelman A, Pachter N, Ahmed M, Cajal TRY, Krajc M, Cleaver R, Cruellas M, Perez-Ballestero E, Brady AF, Gallagher D, Donaldson A, Barwell J, Nicolai N, Friedman E, Hall MJ, Greenhalgh L, Murthy V, Copakova L, McGrath JS, Cooke P, Arun B, Myhill K, Hogben M, Hussain S, Aaronson NK, Ardern-Jones A, Bangma CH, Castro E, Dearnaley D, Eccles DM, Tricker K, Falconer A, Gronberg H, Hamdy FC, Khoo V, Lilja H, Lindeman GJ, Lubinski J, Axcrona K, Mikropoulos C, Mitra A, Offman J, Rennert G, Suri M, Dudderidge T, IMPACT Study Collaborators, Brook MN, Kote-Jarai Z, Eeles RA
High 11-Ketotestosterone Linked to Shorter Time to Castration Resistance in Recurrent Nonmetastatic Prostate Cancer.
Dahmani C, Caron P, Simonyan D, Lacombe L, Aprikian A, Saad F, Carmel M, Chevalier S, Lévesque E, Guillemette C
Refined Procedure to Purify and Sequence Circulating Cell-Free DNA in Prostate Cancer.
Rahimirad S, Derderian S, Hamel L, Scarlata E, McKercher G, Brimo F, Rajan R, Rompre-Brodeur A, Kassouf W, Sanchez-Salas R, Aprikian A, Chevalier S
Treatment intensification in metastatic castration-sensitive prostate cancer: a real-world study in Alberta, Canada
Steven Yip, Winson Y. Cheung, Armen Garo Aprikian, Matthias Stoelzel, Kelvin A. Wong, Alessandra Pranzo, Thomas W. McLean, Dylan Edmund O'Sullivan, Andrew Chilelli
2025 Canadian Urological Association-Canadian Uro-oncology Group Guideline: Metastatic castration-resistant prostate cancer (Update)
Saad F, So AI, Aprikian A, Finelli A, Fleshner NE, Gleave ME, Hamilou Z, Niazi T, North SA, Pouliot F
Clinical significance of stratifying prostate cancer patients through specific circulating genes.
Derderian S, Jarry E, Santos A, Vesval Q, Hamel L, Sanchez-Salas R, Rompré-Brodeur A, Kassouf W, Rajan R, Brimo F, Duclos M, Aprikian A, Chevalier S
Navigating Focal Therapy for Prostate Cancer: Contemporary Perspectives and Future Trajectories in the Canadian Context.
Hesswani C, Avolio PP, Rompre-Brodeur A, Ghai S, Anidjar M, Kinnaird A, Chin J, Perlis N, Soytas M, Mannas M, Ahmad A, Klotz L, Tanguay S, Kassouf W, McPherson V, Aprikian A, Pinto P, Sanchez-Salas R
Create timely real-world evidence and economic evaluations to improve decisions for patients with prostate cancer
Principal investigators: Dragomir, Alice
Keywords: Drugs Utilisation; Economic Evaluation; Effectiveness And Toxicity Of Treatments; Prostate Cancer; Real-Word Evidence
The McGill Task Force on the Impact of COVID-19 on Cancer Control and Care: Generating Evidence and Developing Strategies to Mitigate Future Cancer Risk for Canadians
Principal investigators: Franco, Eduardo L
Keywords: Administrative Health Databases; Cancer Epidemiology; Cancer Incidence, Mortality, And Survival; Diagnostic Delays; Health Inequalities; Health System Performance; Mathematical Modelling; Pandemic Recovery; Systematic Reviews; Treatment Delays
Use of glycogen synthase kinase-3B inhibitors (GSK3Is) and prostate cancer risk and prognosis
Principal investigators: Righolt, Christiaan
Keywords: Administrative Data; Cancer Chemoprevention; Cancer Registry; Glycogen Synthase Kinase-3ß Inhibitors; Pharmacoepidemiology; Population Health; Prevention; Prostate Cancer; Survival
Mitigating the long-term impact of the COVID-19 epidemic on cancer control and care
Principal investigators: Franco, Eduardo L
Keywords: Cancer Care; Cancer Diagnosis; Cancer Prevention; Cancer Screening; Covid-19; Diagnostic Delay; Patient Delay; Prediction Models; Survival; Treatment Delay
Towards optimization of anti-hormonal therapy in advanced prostate cancer
Principal investigators: Guillemette, Chantal; Levesque, Eric
Keywords: Anti-Androgens; Drug Metabolism; Metabolomics; Pharmacogenomics; Predictive Markers; Prostate Cancer; Steroids
Cancer pharmacoepidemiology: a population-based assessment of the risks of prescription drugs in vulnerable populations
Principal investigators: Azoulay, Laurent
Keywords: Cancer; Drug Safety; Electronic Patient Databases; Epidemiology; Pharmacoepidemiology; Population Based; Public Health
Preoperative delays prior to radical cystectomy and its impacts on survival in patients with bladder cancer: a population-based study
Principal investigators: Santos, Fabiano
Keywords: Bladder Cancer; Preoperative Delays; Radical Cystectomy; Retrospective Cohort Study; Survival; Survival Analysis
Use of statins and prostate cancer risk and prognosis: A population-based study
Principal investigators: Mahmud, Salaheddin
Keywords: Cancer Aetiology; Cancer Epidemiology; Cancer Prognosis; Pharmacoepidemiology; Prostate Cancer; Statins
Statins and the prevention of recurrence and mortality in men with prostate cancer
Principal investigators: Azoulay, Laurent
Keywords: Database; Mortality; Population Based; Prostate Cancer; Recurrence; Statins
A high throughput platform for discovery and noninvasive detection of tumor-specific fusion genes in human cancer
Principal investigators: Chen, Junjian Z
Keywords: Biomarkers; Cancer Diagnosis And Prognosis; Exon Chip; Fusion Genes; Noninvasive Detection; Prostate Cancer
From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.
Frequent collaborators
- Antonio Finelli and Neil Fleshner: 309 shared papers
- Girish Kulkarni and Neil Fleshner: 247 shared papers
- Girish Kulkarni and Antonio Finelli: 182 shared papers
- Antonio Finelli and Ricardo Rendon: 99 shared papers
- Wassim Kassouf and Jonathan Izawa: 97 shared papers
- Wassim Kassouf and Ricardo Rendon: 96 shared papers
- Éric Lévesque and Chantal Guillemette: 87 shared papers
- Jonathan Izawa and Ricardo Rendon: 76 shared papers
- Girish Kulkarni and Wassim Kassouf: 69 shared papers
- Bobby Shayegan and Ricardo Rendon: 68 shared papers
- Girish Kulkarni and Srikala Sridhar: 61 shared papers
- Srikala Sridhar and Neil Fleshner: 60 shared papers
- Wassim Kassouf and Armen Aprikian: 42 shared papers
- Bobby Shayegan and Girish Kulkarni: 39 shared papers
- Srikala Sridhar and Wassim Kassouf: 39 shared papers
- Wassim Kassouf and Alice Dragomir: 39 shared papers
- Bobby Shayegan and Wassim Kassouf: 38 shared papers
- Bobby Shayegan and Jonathan Izawa: 31 shared papers
- Armen Aprikian and Simone Chevalier: 28 shared papers
- Kim Chi and Neil Fleshner: 24 shared papers
- Bobby Shayegan and Philippe Violette: 23 shared papers
- Srikala Sridhar and Kim Chi: 21 shared papers
- Anne-Marie Mes-Masson and Dominique Trudel: 18 shared papers
- Bobby Shayegan and Kim Chi: 17 shared papers
- Girish Kulkarni and Peter Chung: 17 shared papers
- Kim Chi and Fred Saad: 17 shared papers
- Bobby Shayegan and Fred Saad: 15 shared papers
- Neil Fleshner and Armen Aprikian: 15 shared papers
- Srikala Sridhar and Peter Chung: 14 shared papers
- Neil Fleshner and Peter Chung: 14 shared papers
- Ricardo Rendon and Fred Saad: 14 shared papers
- Philippe Violette and Antonio Finelli: 13 shared papers
- Ricardo Rendon and Armen Aprikian: 13 shared papers
- Bobby Shayegan and Armen Aprikian: 12 shared papers
- Philippe Violette and Wassim Kassouf: 12 shared papers
- Alice Dragomir and Ricardo Rendon: 11 shared papers
- Srikala Sridhar and Normand Blais: 10 shared papers
- Alice Dragomir and Armen Aprikian: 10 shared papers
- Srikala Sridhar and Piotr Czaykowski: 9 shared papers
- Wassim Kassouf and Normand Blais: 9 shared papers
- Éric Lévesque and Armen Aprikian: 8 shared papers
- Éric Lévesque and Simone Chevalier: 8 shared papers
- Chantal Guillemette and Armen Aprikian: 8 shared papers
- Chantal Guillemette and Simone Chevalier: 8 shared papers
- Srikala Sridhar and Armen Aprikian: 8 shared papers
- Anne-Marie Mes-Masson and Neil Fleshner: 8 shared papers
- Armen Aprikian and Fred Saad: 8 shared papers
- Anne-Marie Mes-Masson and Simone Chevalier: 7 shared papers
- Girish Kulkarni and Normand Blais: 6 shared papers
- Éric Lévesque and Piotr Czaykowski: 6 shared papers
- Dominique Trudel and Neil Fleshner: 6 shared papers
- Dominique Trudel and Armen Aprikian: 6 shared papers
- Wassim Kassouf and Libni Eapen: 6 shared papers
- Armen Aprikian and Peter Chung: 6 shared papers
- Srikala Sridhar and Libni Eapen: 5 shared papers
- Antonio Finelli and Armen Aprikian: 5 shared papers
- Neil Fleshner and Libni Eapen: 5 shared papers
- Girish Kulkarni and Armen Aprikian: 4 shared papers
- Laurent Azoulay and Armen Aprikian: 4 shared papers
- Anne-Marie Mes-Masson and Armen Aprikian: 4 shared papers
- Kim Chi and Armen Aprikian: 4 shared papers
- John Lewis and Adam Kinnaird: 4 shared papers
- Libni Eapen and Armen Aprikian: 4 shared papers
- Jonathan Izawa and Armen Aprikian: 4 shared papers
- Bobby Shayegan and Adam Kinnaird: 3 shared papers
- Philippe Violette and Armen Aprikian: 3 shared papers
- Srikala Sridhar and Adam Kinnaird: 3 shared papers
- Piotr Czaykowski and Armen Aprikian: 3 shared papers
- John Lewis and Armen Aprikian: 3 shared papers
- Armen Aprikian and Adam Kinnaird: 3 shared papers
- Armen Aprikian and Normand Blais: 3 shared papers
- John Lewis and Jonathan Izawa: 1 shared paper
- Department of Surgery
- Department of Medicine
- Cancer Research Centre
- Gerald Bronfman Department of Oncology
- Department of Urology
- Department of Pathology and Cell Biology
- Department of Radiation Oncology
- Other
Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Wassim Kassouf
Department of Surgery
42 shared papers, latest 2025
Simone Chevalier
Department of Medicine
28 shared papers, latest 2026
Neil Fleshner
Department of Surgery
15 shared papers, latest 2026
Alan So
Department of Urologic Sciences
13 shared papers, latest 2025
Ricardo Rendon
Department of Urology
13 shared papers, latest 2025
Bobby Shayegan
Department of Surgery
12 shared papers, latest 2025
Alice Dragomir
Faculty
10 shared papers, latest 2018
Martin Gleave
Department of Urologic Sciences
9 shared papers, latest 2026
Fred Saad
Department of Surgery
8 shared papers, latest 2026
Chantal Guillemette
Cancer Research Centre
8 shared papers, latest 2026
Éric Lévesque
Cancer Research Centre
8 shared papers, latest 2026
Srikala Sridhar
Department of Medicine
8 shared papers, latest 2025
Peter Chung
Department of Radiation Oncology
6 shared papers, latest 2022
Dominique Trudel
Department of Pathology and Cell Biology
6 shared papers, latest 2026
Antonio Finelli
Department of Surgery
5 shared papers, latest 2025
Eric Vigneault
Faculty
4 shared papers, latest 2025
Nawaid Usmani
Department of Electrical and Computer Engineering
4 shared papers, latest 2025
Kim Chi
Department of Urologic Sciences
4 shared papers, latest 2025
Girish Kulkarni
Institute of Health Policy, Management, and Evaluation
4 shared papers, latest 2020
Jonathan Izawa
Department of Surgery
4 shared papers, latest 2018
Anne-Marie Mes-Masson
Medicine
4 shared papers, latest 2026
Libni Eapen
Radiology
4 shared papers, latest 2020
Laurent Azoulay
Epidemiology, Biostatistics and Occupational Health
4 shared papers, latest 2019
Adam Kinnaird
Surgery Dept
3 shared papers, latest 2026
Normand Blais
Department of Medicine
3 shared papers, latest 2023
Michael Jewett
Department of Surgery
2 shared papers, latest 2017
Annie Rochette
Faculty
1 shared papers, latest 2017
Claudie Laprise
Department of Social and Preventive Medicine
1 shared papers, latest 2019
Nicole Ricard
Faculty
1 shared papers, latest 2006
Alain Bergeron
Cancer Research Centre
1 shared papers, latest 2026
Yves Fradet
Cancer Research Centre
1 shared papers, latest 2026
Louis Lacombe
Cancer Research Centre
1 shared papers, latest 2026
Pierre Fiset
Department of Anesthesia
1 shared papers, latest 2013
Lori Wood
Division of Medical Oncology
1 shared papers, latest 2022
Alina Lalani
Faculty
1 shared papers, latest 2020
Andrew Matthew
Department of Surgery
1 shared papers, latest 2022
Martin O'Malley
JDMI - Princess Margaret Cancer Centre
1 shared papers, latest 2022
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.